PortfoliosLab logoPortfoliosLab logo
CBAT vs. ARCT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CBAT vs. ARCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CBAK Energy Technology, Inc. (CBAT) and Arcturus Therapeutics Holdings Inc. (ARCT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


CBAT

1D
-1.42%
1M
6M
YTD
1Y
3Y*
5Y*
10Y*

ARCT

1D
-3.73%
1M
-3.73%
6M
-10.89%
YTD
9.46%
1Y
-51.31%
3Y*
-42.58%
5Y*
-24.79%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CBAT vs. ARCT - Yearly Performance Comparison


Correlation

The correlation between CBAT and ARCT is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jun 30, 2026

0.02

Fundamentals

Market Cap

CBAT:

$44.32M

ARCT:

$190.72M

EPS

CBAT:

-$0.10

ARCT:

-$1.80

PS Ratio

CBAT:

0.23

ARCT:

3.97

PB Ratio

CBAT:

0.00

ARCT:

1.00

Total Revenue (TTM)

CBAT:

$195.19M

ARCT:

$46.80M

Gross Profit (TTM)

CBAT:

$18.42M

ARCT:

$40.72M

EBITDA (TTM)

CBAT:

-$18.44M

ARCT:

-$84.61M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CBAT vs. ARCT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBAT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


ARCT
ARCT Risk / Return Rank: 2323
Overall Rank
ARCT Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
ARCT Sortino Ratio Rank: 2525
Sortino Ratio Rank
ARCT Omega Ratio Rank: 2424
Omega Ratio Rank
ARCT Calmar Ratio Rank: 1818
Calmar Ratio Rank
ARCT Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CBAT vs. ARCT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CBAK Energy Technology, Inc. (CBAT) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CBATARCTDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.95

Calmar ratioReturn relative to maximum drawdown

-0.69

Martin ratioReturn relative to average drawdown

-0.90

CBAT vs. ARCT - Sharpe Ratio Comparison


Loading charts...

Drawdowns

CBAT vs. ARCT - Drawdown Comparison

The maximum CBAT drawdown since its inception was -17.42%, smaller than the maximum ARCT drawdown of -95.23%. Use the drawdown chart below to compare losses from any high point for CBAT and ARCT.


Loading charts...

Drawdown Indicators


CBATARCTDifference

Max Drawdown

Largest peak-to-trough decline

-17.42%

-95.23%

+77.81%

Max Drawdown (1Y)

Largest decline over 1 year

-74.53%

Max Drawdown (3Y)

Largest decline over 3 years

-86.71%

Max Drawdown (5Y)

Largest decline over 5 years

-89.87%

Current Drawdown

Current decline from peak

-17.42%

-94.57%

+77.15%

Average Drawdown

Average peak-to-trough decline

-10.35%

-73.29%

+62.94%

Ulcer Index

Depth and duration of drawdowns from previous peaks

57.22%

Volatility

CBAT vs. ARCT - Volatility Comparison


Loading charts...

Volatility by Period


CBATARCTDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.41%

Volatility (6M)

Calculated over the trailing 6-month period

40.17%

Volatility (1Y)

Calculated over the trailing 1-year period

71.91%

91.90%

-19.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.91%

91.74%

-19.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

71.91%

101.63%

-29.72%

Dividends

CBAT vs. ARCT - Dividend Comparison

Neither CBAT nor ARCT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CBAT vs. ARCT - Financials Comparison

This section allows you to compare key financial metrics between CBAK Energy Technology, Inc. and Arcturus Therapeutics Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
58.80M
2.06M
(CBAT) Total Revenue
(ARCT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CBAT and ARCT have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for CBAT and ARCT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer